US-based pharmaceutical marketing company PharmaKinnex has partnered with technology company Data360 with the aim of enhancing patient outcomes.

The partnership will use Data360's Fingerprint AI technology to identify and target healthcare professionals and patients who are searching for rare diseases online.

Data360 president and CEO James Miller said: "We are eager to partner with PharmaKinnex and contribute our solutions that identify and engage relevant audiences throughout their digital life, and so improve the patient journey experience.

"For this unique market offering, Data360 will identify healthcare professionals and patients searching online for rare diseases by activating our Fingerprint AI solution.

"By providing insights for timeliness, relevance and intent behaviour, Data360 will equip PK with valuable insights and reach to elevate its services to clients."

Fingerprint AI is a technology that uses online behaviour and search criteria to identify and target healthcare audiences.

This is expected to allow PharmaKinnex to reach more potential patients and prescribers.

The partnership aims to enable more secure data analysis and connect patients with life-saving treatments while increasing profits for clients.

PharmaKinnex CEO Michael White said: "The strategic partnership aligns perfectly with our mission to bring unprecedented value to our clients.

"Data360's powerful solutions to identify, target, and engage individuals, while providing valuable analytics about those audiences, will extend our reach to more potential patients and prescribers, providing a sizable edge in the rare disease sector."

Based in New Jersey, PharmaKinnex offers multichannel marketing services for companies in the life sciences industry.

The company aims to provide a 'profitable, scalable and adaptable' inside sales solution that increases sales and flexibility.

Based in Delaware, Data360 provides its clients with access to a fully authenticated database of healthcare providers.

The company's services are intended to provide 'broader and better' access to physicians, healthcare providers, patients and caregivers by turning data into intelligence.